
via www.purdue.edu
Scientists are making the case that a vaccine against rhinoviruses, the predominant cause of the common cold, is achievable.
The quest for a vaccine against rhinoviruses may have seemed quixotic, because there are more than 100 varieties circulating around the world. Even so, the immune system can handle the challenge, researchers from Emory University School of Medicine and Children’s Healthcare of Atlanta say.
Vaccines that combine dozens of varieties of rhinovirus at once are effective in stimulating antiviral antibodies in mice and monkeys, the researchers report in Nature Communications. The paper was also posted on Biorxiv before publication.
“We think that creating a vaccine for the common cold can be reduced to technical challenges related to manufacturing,” says Martin Moore, PhD, associate professor of pediatrics at Emory University School of Medicine.
Rhinoviruses are the most common cause of the common cold; other viruses such as respiratory syncytial virus, parainfluenza virus and adenoviruses can cause them too. Rhinoviruses also exacerbate asthma attacks. Although they come in many varieties, rhinoviruses do not drift to the same degree that influenza viruses do, Moore says.
Researchers showed in the 1960s that it was possible to vaccinate people against one variety of rhinovirus and prevent them from getting sick when challenged with samples of the same virus. The trouble was the sheer diversity of rhinoviruses – or that’s how it appeared at the time.
“It’s surprising that nobody tried such a simple solution over the last 50 years. We just took 50 types of rhinovirus and mixed them together into our vaccine, and made sure we had enough of each one,” Moore says. “If we make a vaccine with 50 or 100 variants, it’s the same amount of total protein in a single dose of vaccine. The variants are like a bunch of slightly different Christmas ornaments, not really like 50 totally different vaccines mixed.”
A mixture of 25 types of inactivated rhinovirus can stimulate neutralizing antibodies against all 25 in mice, and a mixture of 50 types can do the same thing in rhesus macaques. In this paper, antibodies generated in response to the vaccine were tested for their ability to prevent the virus from infecting human cells in culture. However, the vaccines were not tested for their ability to stop animals from getting sick.
“There are no good animal models of rhinovirus replication,” Moore says. “The next step would be human challenge models with volunteers, which are feasible because the virus is not very pathogenic.”
Emory has optioned the vaccine technology to a startup company, Meissa Vaccines, Inc., which is pursuing a product development plan with support from the National Institute of Allergy and Infectious Diseases’ vaccine manufacturing services.
Learn more: Vaccine vs many common cold viruses achievable
The Latest on: Vaccine against rhinoviruses
via Google News
The Latest on: Vaccine against rhinoviruses
- Can You Catch the Flu and a Cold at the Same Time? on February 5, 2019 at 4:01 pm
These telltale signs can be caused by a number of pathogens, but the most common culprit is rhinovirus ... s why getting an annual flu shot or nasal spray vaccine is the best way to safeguard against ... […]
- Vaccines Against a Vanishing Virus? on September 25, 2018 at 5:53 am
If you’re going to prove that a Zika vaccine works, a human challenge may be the only way. Doing that with rhinovirus is considered completely acceptable, while doing that with (say) Ebola is complete... […]
- Why Haven’t We Cured The Common Cold Yet? on September 7, 2018 at 11:44 am
says virologist Martin Moore of Meissa Vaccines, a company currently developing an inoculation against rhinovirus. “You’ve got this great number of serotypes that circulate all the time, and that real... […]
- We have a good chance of curing the common cold in next ten years – a scientist explains on June 18, 2018 at 8:18 am
and it’s extremely difficult to make a vaccine or antiviral that will cover all of them. There are only around 90 to 95 antivirals in total – far fewer than our arsenal of antibiotics – and none have ... […]
- Chip identifies rhinoviruses as a cause of asthma : Study on June 18, 2018 at 7:34 am
This paves the way for developing a new vaccine which should protect against these particularly dangerous viruses. Certain rhinoviruses are responsible for up to 80% of all asthma attacks. Viral asthm... […]
- Chip identifies rhinoviruses as cause of asthma on June 18, 2018 at 5:42 am
This paves the way for developing a new vaccine which should protect against these particularly dangerous viruses. Certain rhinoviruses are responsible for up to 80% of all asthma attacks. Viral asthm... […]
- Meissa Vaccines Appoints Dr. Lawrence Blatt as Chairman of the Board of Directors on March 13, 2018 at 3:00 am
"I was impressed with quality of the science and technology behind Meissa's creative and robust approach to tailor-make viruses for vaccines against specific diseases ... human metapneumovirus, and rh... […]
- 'Vaccine against HIV infection closer to reality' on November 21, 2016 at 12:08 am
MELBOURNE: In a significant progress towards the development of a vaccine against HIV ... in attempts to introduce a first line of defence against HIV at the site of infection. "In mice, we delivered ... […]
- Scientists think the common cold may at last be beatable on October 20, 2016 at 12:21 pm
Three years later, Moore and his colleagues now have a vaccine that has shown promising results in trials on macaques. The monkeys were able to produce antibodies against many types of rhinoviruses. M... […]
via Bing News